Stealth BioTherapeutics Welcomes David A. Brown, Ph.D., as Chief Scientific Officer to Lead Mitochondrial Innovations Stealth BioTherapeutics appoints Dr. David A. Brown as Chief Scientific Officer to enhance its pioneering research in mitochondrial medicine.

Stealth BioTherapeutics Welcomes David A. Brown, Ph.D., as Chief Scientific Officer to Lead Mitochondrial Innovations #USA #Needham #Stealth_BioTherapeutics #David_A._Brown #Mitochondrial_Medicine